STAP-1 deficiency inhibits STAT5 phosphorylation, and downregulation of antiapoptotic genes, such as Bcl-2 and Bcl-xL, in CML LSCs (Fig. 6). This evidence concerns the gene STAT5B and chronic myelogenous leukemia, BCR-ABL1 positive.